Immersive Training in Glycosciences

糖科学沉浸式培训

• 批准号: 10197206
• 负责人: VINCENT CHARLES HASCALL
• 金额: $ 95.93万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-01 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10197206
• 关键词: Biomedical Engineering; Biomedical Research; Cardiology; Clinic; Clinical; Development; Disease; Doctor of Medicine; Doctor of Philosophy; Faculty; Fellowship Program; Grant; Immersion; Individual; Knowledge; Learning; Mentors; Molecular; Monitor; National Heart, Lung, and Blood Institute; Physicians; Polysaccharides; Program Development; Publications; Pulmonology; Research; Review Literature; Scientist; Series; System; Training; Translational Research; Universities; Writing; career; career development; experience; human disease; laboratory curriculum; lectures; next generation; programs; recruit; skills; success

The program directors and faculty from three of the six prior NHLBI Program of Excellence in Glycoscience (PEG) centers have joined forces with top quality physician scientists at the Cleveland Clinic and at Johns Hopkins to create a unique career development program that will train the next generation of leaders in biomedical research involving glycans and human disease. Scholars will be selected by either an advertised national search or by selecting individuals who were already nationally recruited by highly competitive searches to local fellowship programs in cardiology, pulmonology or biomedical engineering. Five scholars will be selected during the first cycle of the Program. Five additional Scholars will be selected in the second cycle of the Program. Each Scholar will have at-least two co-mentors, one a leading expert in glycoscience and the other(s) leading experts in clinical/translational research on a disease of high priority to NHLBI. Selection of Scholars will favor individuals with the M.D. or M.D.-Ph.D. degree. The objectives of our career development program are to provide immersion in state-of-the art glycosciences relevant to human disease for both Scholars and their clinical co-mentors. The career development program will consist of a multi-faceted immersion in disease-related glycosciences. Research experiences will be supplemented by a) advanced topic lectures; b) translational glycoscience examples & applications; c) thematic literature reviews; d) glycoscience seminar series; and e) research in progress. This training will be simulcast at the Cleveland Clinic or Johns Hopkins University (JHU) as needed. f) Scholars will also take a hands-on laboratory course, where they will learn major skills required to do research in glycosciences. Biomedical glycoscience career development will be further supported by professional development opportunities, focused on grant writing, presentation skills, and networking. Attendance at all Program activities by Scholars will be mandatory. Participation and progress of Scholars will be collectively overseen by the internal oversight committee, comprised of all of the Co-P.I.s. A formal electronic system for evaluating both the Scholars and mentors will be established. The overall Program will be evaluated annually by an outside review panel, comprised of leading glycoscientists. We will also monitor publications, presentations and career trajectories of present and former Scholars to evaluate the overall success of the Program. Our Program will create a cadre of physician scientists who not only will become leaders in disease-related research, but also will be well versed in the glycosciences required to understand the molecular basis of disease. True success of the Program will occur as these Scholars are now able to pass on their knowledge of the importance of glycans to their own Fellows when they become independent physician scientists.

之前六个 NHLBI 卓越计划中的三个的项目主管和教员 糖科学 (PEG) 中心与克利夫兰诊所的顶尖医师科学家联手 并在约翰·霍普金斯大学创建了一个独特的职业发展计划，以培训下一代 涉及聚糖和人类疾病的生物医学研究的领导者。学者将由以下任一机构选拔： 广告全国搜索或通过选择已经在全国范围内招聘的人员 竞争性搜索当地心脏病学、肺病学或生物医学工程领域的奖学金项目。 该计划的第一周期将选出五名学者。将选出另外五名学者 在该计划的第二个周期中。每位学者将至少有两名共同导师，其中一名是该领域的领先专家 糖科学和其他高度优先疾病临床/转化研究的领先专家 到 NHLBI。学者的选择将优先考虑拥有医学博士或医学博士-博士学位的个人。程度。的目标 我们的职业发展计划是让学生沉浸在与以下领域相关的最先进的糖科学中： 学者及其临床合作导师的人类疾病。职业发展计划将 包括对疾病相关糖科学的多方面沉浸。研究经验将是 辅以a) 高级主题讲座； b) 转化糖科学示例和应用； c) 专题文献综述； d) 糖科学系列研讨会； e) 正在进行的研究。此次培训将 根据需要在克利夫兰诊所或约翰·霍普金斯大学 (JHU) 联播。 f) 学者们还将采取 实践实验室课程，他们将学习糖科学研究所需的主要技能。 生物医学糖科学职业发展将得到专业发展的进一步支持 机会，重点是资助写作、演讲技巧和网络。参加所有计划 学者的活动将是强制性的。学者的参与和进展将受到集体监督 由内部监督委员会负责，该委员会由所有 Co-P.I. 组成。正式的电子系统 将建立对学者和导师的评估。将对总体计划进行评估 每年由一个由领先的糖科学家组成的外部审查小组进行审查。我们还将监控出版物， 现任和前任学者的演讲和职业轨迹，以评估该项目的整体成功 程序。我们的计划将培养一支医学科学家骨干队伍，他们不仅将成为医学领域的领导者 疾病相关的研究，但也将精通了解所需的糖科学 疾病的分子基础。由于这些学者现在能够通过考试，因此该计划将取得真正的成功 当他们独立时，他们了解聚糖对自己的研究员的重要性 医师科学家。